Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy

Coronavirus disease 2019 (COVID-19) may have a metabolic origin given strong links with risk factors such as lipids and glucose and co-morbidities such as obesity and type 2 diabetes mellitus. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein mediates viral cellular entr...

Descripción completa

Detalles Bibliográficos
Autores principales: Heffernan, Kevin S., Ranadive, Sushant M., Jae, Sae Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430295/
https://www.ncbi.nlm.nih.gov/pubmed/33017906
http://dx.doi.org/10.1016/j.mehy.2020.110197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430295/
https://www.ncbi.nlm.nih.gov/pubmed/33017906
http://dx.doi.org/10.1016/j.mehy.2020.110197

Ejemplares similares